A recent survey by Maharashtra's Food and Drugs Administration shows that an IV set that costs just ₹11 at the factory is sold to patients for ₹325, a profit margin of 2,800%.
The same study uncovered similar spikes elsewhere: a 10‑ml syringe that costs ₹6.75 is priced at ₹57.20, a nebuliser mask costing ₹40 sells for ₹715, and a simple IV cannula priced at ₹22.50 is billed at ₹424. These numbers point to a broader pattern of price inflation across inpatient consumables.
For patients, the impact is twofold. First, the extra expense can strain household budgets and discourage timely treatment. Second, because patients have no bargaining power in the hospital setting, they end up bearing the entire cost of essential care, potentially compromising adherence to treatment plans.
If you’re heading to a hospital or already a patient, start by asking for a printed price list of consumables. Compare the listed prices with the manufacturer’s procurement cost, which is often available on the product’s packaging or through the hospital’s pharmacy. If a price seems unusually high, request a cost breakdown from the billing department. Finally, remember that devices listed under the Drugs (Prices Control) Order can be subject to regulatory caps—bringing the issue to a state health official or patient advocacy group can help trigger a review.
In short, staying informed and asking the right questions can help you avoid paying inflated prices for life‑saving supplies.